Elke Lipka

Tsrl, Inc.

NIH Rank #2238
  • Early Career

NIH Funding · FY2024

Total Funding
$3.3M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#2,238
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.3M across 4 grants · National rank #2238.

Top grants by award amount

Elke Lipka's NIH grant portfolio, ranked by award amount.

  • 4R44AI179506-02R44
    Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu
    $999.7K
    award amount
  • 5R44AI129122-08R44
    Microneedle Delivery of Zanamivir for the Treatment of Influenza Infections
    $998.7K
    award amount
  • 5R44AI134190-05R44
    Development of MRS-2541, a methionyl-tRNA synthetase inhibitor, for Gram positive bacterial infections.
    $997.7K
    award amount
  • 1U44AI184201-01U44
    Phase 1 Clinical Trial to Assess the Pharmacokinetics, Safety and Tolerance of a Zanamivir Transdermal System in Healthy Subjects
    $292.7K
    award amount

Affiliation

Institutions that have administered grants for Elke Lipka.

Affiliated with Tsrl, Inc. (MI).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Tsrl, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2238
  6. 2024
    Entered Top 25% Nationally
    Ranked #2238